Statement of Changes in Beneficial Ownership (4)
June 15 2020 - 7:02PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
SCHWARTZ NORMAN D |
2. Issuer Name and Ticker or Trading Symbol
BIO-RAD LABORATORIES, INC.
[
BIO, BIOB
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chairman, President, and CEO |
(Last)
(First)
(Middle)
C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
6/12/2020 |
(Street)
HERCULES, CA 94547
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Bio-Rad A Common Stock | | | | | | | | 415182 | D | |
Bio-Rad B Common Stock | 6/12/2020 | | M | | 37000 | A | $84.57 | 316982 | D | |
Bio-Rad B Common Stock | 6/12/2020 | | F | | 21860 | D | $448.85 | 295122 | D | |
Bio-Rad B Common Stock | | | | | | | | 12811 | I | By Spouse (1) |
Bio-Rad B Common Stock | | | | | | | | 4060054 | I | By Blue Raven Partners, L.P. (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-Qualified Stock Option (right to buy) | $84.57 | 6/12/2020 | | M | | | 37000 | (3) | 9/8/2020 | Bio-Rad B Common Stock | 37000 | $0 | 0 | D | |
Explanation of Responses: |
(1) | The reporting person disclaims beneficial ownership of these shares. |
(2) | The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
(3) | The option vested in five equal annual installments beginning on September 8, 2011. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
SCHWARTZ NORMAN D C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES, CA 94547 | X | X | Chairman, President, and CEO |
|
Signatures
|
Norman D. Schwartz | | 6/15/2020 |
**Signature of Reporting Person | Date |
Bio Rad Laboratories (NYSE:BIO.B)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bio Rad Laboratories (NYSE:BIO.B)
Historical Stock Chart
From Sep 2023 to Sep 2024